TBC I LLC

RICHMOND, VA · Founded 2014 · CIK 0001653120 · Biotech

AI models augmented with real biological neurons for improved performance and reduced cost

tbc.co →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.0M
1 Form D · Sep 2015
133 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1850ASP Isotopes Inc.—$5.0M
1851Kymera Therapeutics——
1852VERSAPEUTICS INC—$3.8M
1853TBC I LLC—$1.0M
1854InCarda Therapeutics, Inc.—$66M
1855Recombinetics, Inc.—$45M
1856Dracen Pharmaceuticals, Inc.—$19M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • A. Ewing, IIIExecutive Officer
  • Mark MurrayExecutive Officer
  • Thomas WillinghamExecutive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.